NTC
North Tide Capital Portfolio holdings
AUM
$469M
This Quarter Return
+2.03%
1 Year Return
+6.55%
3 Year Return
+14.78%
5 Year Return
–
10 Year Return
–
AUM
$469M
AUM Growth
+$469M
(+4.3%)
Cap. Flow
-$180M
Cap. Flow
% of AUM
-38.37%
Top 10 Holdings %
Top 10 Hldgs %
91.11%
Holding
16
New
4
Increased
4
Reduced
4
Closed
3
Top Buys
| 1 |
McKesson
MCK
|
$53.8M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$22.2M |
| 3 |
CVS Health
CVS
|
$20.3M |
| 4 |
IVC
Invacare Corporation
IVC
|
$16.1M |
| 5 |
Viatris
VTRS
|
$11M |
Top Sells
| 1 |
SVU
SUPERVALU Inc.
SVU
|
$174M |
| 2 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$71.4M |
| 3 |
Gilead Sciences
GILD
|
$40.5M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$16.1M |
| 5 |
Select Medical
SEM
|
$9.6M |
Sector Composition
| 1 | Healthcare | 87.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Select Medical
SEM
$1.61B
| $86.4M | 18.43% | 4,500,000 -500,000 | -10% | -$9.6M |
|
|
2
McKesson
MCK
$85.4B
| $76.8M | 16.38% | 500,000 +350,000 | +233% | +$53.8M |
|
|
SVU
3
DELISTED
SUPERVALU Inc.
SVU
| $43.5M | 9.28% | 2,000,001 -7,999,999 | -80% | -$174M |
|
|
4
Viatris
VTRS
$12.3B
| $42.4M | 9.03% | 1,350,000 +350,000 | +35% | +$11M |
|
|
5
Gilead Sciences
GILD
$140B
| $40.5M | 8.64% | 500,000 -500,000 | -50% | -$40.5M |
|
|
ENDP
6
DELISTED
Endo International plc
ENDP
| $34.3M | 7.31% | 4,000,000 +1,000,000 | +33% | +$8.57M |
|
|
TVTY
7
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $30.6M | 6.53% | 750,000 -1,750,000 | -70% | -$71.4M |
|
8
Perrigo
PRGO
$3.27B
| $25.4M | 5.42% | 300,000 | – | – |
|
9
Tenet Healthcare
THC
$16.3B
| $25.2M | 5.38% | 1,534,200 +534,200 | +53% | +$8.78M |
|
|
ESRX
10
DELISTED
Express Scripts Holding Company
ESRX
| $22.2M | 4.73% | +350,000 | New | +$22.2M |
|
|
11
CVS Health
CVS
$92.8B
| $20.3M | 4.34% | +250,000 | New | +$20.3M |
|
|
IVC
12
DELISTED
Invacare Corporation
IVC
| $16.1M | 3.44% | +1,023,000 | New | +$16.1M |
|
13
Pacific Biosciences
PACB
$393M
| $5.25M | 1.12% | +1,000,000 | New | +$5.25M |
|
14
Option Care Health
OPCH
$4.65B
| – | – | -3,000,000 | Closed | -$8.15M |
|
|
IPXL
15
DELISTED
Impax Laboratories, Inc.
IPXL
| – | – | -1,000,000 | Closed | -$16.1M |
|
|
VVUS
16
DELISTED
Vivus Inc
VVUS
| – | – | -5,000,000 | Closed | -$6.1M |
|